Semax
Synthetic heptapeptide (ACTH(4-7) analog)
Semax is a synthetic heptapeptide derived from the ACTH(4-7) fragment. In the scientific literature it appears in neurological research, where attention has focused on peptide interactions in laboratory and model systems. This page provides neutral background about the molecule as a research material; it is not medical guidance and not for human or veterinary use.
Classification and structure
Semax is classified as a synthetic heptapeptide, an analog of the 4-7 fragment of adrenocorticotropic hormone (ACTH) extended with a Pro-Gly-Pro sequence. Its structure consists of seven linked amino-acid residues. It is handled exclusively as a research chemical for non-clinical laboratory investigation.
Areas of research
In the published literature, Semax appears in the following research areas.
- Neurological research — Studied in models examining neuropeptide activity, neural signaling, and brain-derived factors.
- Neurochemistry — Investigated in relation to peptide stability and receptor-level interactions in vitro.
As always in this library, describing a compound as “studied in” an area is a statement about where scientific attention has gone — not a claim that it produces any result in humans or animals.
Handling and verification
Store lyophilized material cold and protected from light and moisture; stability is reduced once reconstituted or opened. Every in-stock lot ships with a verifiable third-party Certificate of Analysis (COA).
Frequently asked
What is Semax?
Semax is a synthetic heptapeptide analog of ACTH(4-7), supplied for laboratory research use only.
Is it approved for use?
No. It is a research chemical and is not approved for human or veterinary use.
What research is it associated with?
It appears in neurological research and neurochemistry literature. Describing it as 'studied in' an area reflects where scientific attention has gone, not a claim of any result.
How do I confirm a lot is genuine?
Every lot has a certificate and a verifiable number — enter it on the verification page.